Detection of IgG-class antibodies to measles, mumps, rubella, and varicella-zoster virus using a multiplex bead immunoassay

Diagnostic Microbiology and Infectious Disease

Volumn 67, Issue 4, 2010, Pages 346-349

  Dhiman, Neelam ^a   Jespersen, Deborah J ^a   Rollins, Leonard O ^a   Harring, Julie A ^a   Beito, Elaine M ^a   Binnicker, Matthew J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Antibodies; Measles; Multiplex bead immunoassay; Mumps; Rubella; Varicella

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY; ANTIBODY; DIAGNOSTIC KIT; IMMUNOGLOBULIN G; MICROSPHERE;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; ENZYME LINKED FLUORESCENT ANTIBODY; FLUORESCENT ANTIBODY TECHNIQUE; HERPES ZOSTER; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEASLES; MEASLES VIRUS; MUMPS; MUMPS VIRUS; PREDICTION; PRIORITY JOURNAL; RUBELLA; RUBELLA VIRUS; SCREENING TEST; SENSITIVITY AND SPECIFICITY; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; BLOOD; DIAGNOSTIC KIT; EVALUATION STUDY; IMMUNOLOGY; PROCEDURES; VIROLOGY;

ANTIBODIES; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; MEASLES; MEASLES VIRUS; MICROSPHERES; MUMPS; MUMPS VIRUS; REAGENT KITS, DIAGNOSTIC; RUBELLA; RUBELLA VIRUS; VIROLOGY;

EID: 77954735318     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.03.008     Document Type: Article

References (13)

1. Binnicker M.J., Jespersen D.J., Harring J.A., Rollins L.O., Beito E.M. Evaluation of a multiplex flow immunoassay for detection of Epstein-Barr virus-specific antibodies. Clin Vaccine Immunol 2008, 15:1410-1413.
2. Czajka H., Schuster V., Zepp F., Esposito S., Douha M., Willems P. A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile. Vaccine 2009, 27:6504-6511.
3. Doshi S., Khetsuriani N., Zakhashvili K., Baidoshvili L., Imnadze P., Uzicanin A. Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts. Int J Epidemiol 2009, 38:182-191.
4. Kancherla V.S., Hanson I.C. Mumps resurgence in the United States. J Allergy Clin Immunol 2006, 118:938-941.
5. Landis J.R.K.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
6. Mahony J.B., Blackhouse G., Babwah J., Smieja M., Buracond S., Chong S., Ciccotelli W., O'Shea T., Alnakhli D., Griffiths-Turner M., Goeree R. Cost analysis of multiplex PCR testing for diagnosing respiratory virus infections. J Clin Microbiol 2009, 47:2812-2817.
7. Mulholland E.K. Measles in the United States, 2006. N Engl J Med 2006, 355:440-443.
8. Plotkin S.A. Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J 2001, 20:63-75.
9. Plotkin S.A. Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 2008, 47:401-409.
10. Schuster V., Otto W., Maurer L., Tcherepnine P., Pfletschinger U., Kindler K., Soemantri P., Walther U., Macholdt U., Douha M., Pierson P., Willems P. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life. Pediatr Infect Dis J 2008, 27:724-730.
11. Tamer G.S., Dundar D., Caliskan E. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey. Clin Invest Med 2009, 32:E43-47.
12. WHO Varicella vaccines. WHO position paper. Wkly Epidemiol Rec 1998, 73:241-248.
13. WHO Progress towards the 2012 measles elimination goal in WHO's Western Pacific Region, 1990-2008. Wkly Epidemiol Rec 2009, 84:271-279.